Personalized approach in the management of children with cardiorenal syndrome (combined congenital heart and kidney defects)
https://doi.org/10.18705/2782-3806-2023-3-2-77-81
Abstract
Today’s personalized medicine represents an integral model for the selection of diagnostic, therapeutic agents and preventive measures that are optimal for a particular individual, taking into account his genetic, physiological, biochemical, psychosocial and other characteristics.
The presence of a special relationship between the cardiovascular system and the kidneys are confirmed by a significant difference in mortality from malformations and in the population. The possibility of prenatal diagnosis of malformations sets the task of a special approach to the management of such patients, which can provide a personalized approach.
The article presents the experience of a personalized approach to the management of children with cardiorenal syndrome (combined congenital heart and kidney defects).
About the Authors
T. M. Pervunina
Almazov National Medical Research Centre; Saint Petersburg State University
Russian Federation
Russian Federation
Pervunina Tatyana M. - MD, Director of the Institute of Perinatology and Pediatrics.
Akkuratova str., 2, Saint Petersburg, 197341
E. S. Vasichkina
Almazov National Medical Research Centre
Russian Federation
Russian Federation
Vasichkina Elena S. - MD, Head of the Scientific Research Center for Unknown, Rare and Genetically Caused Diseases of the World-Class Research Centre for Personalized Medicine.
St. Petersburg
M. V. Erman
Saint Petersburg State University
Russian Federation
Russian Federation
Erman Mikhail V. - professor, Head of the Department of Pediatrics, Faculty of Medicine.
St. Petersburg
References
1. Jain RR. Personalized Medicine / Decision Resources Inc. Waltham, MA, USA, 1998.
2. Abrahams E. The History of Personalized Medicine / E. Abrahams, M. Silver // Integrative Neuroscience and Personalized Medicine / eds. E. Gordon, S. Koslow. New York: Oxford University Press. 2010. Ch. 1. P. 3–16.
3. Tezak Z, Kondratovich MV, Mansfield E. US FDA and personalized medicine: in vitro diagnostic regulatory perspective // Personalized Medicine. 2010;7(5):517–530.
4. Курцер М. Революция — это персонифицированная медицина // РБК. 2014. № 12–1.
5. Пальцев М.А. Персонифицированная медицина // Наука в России. 2011. № 1. С. 12–17.
6. Source: The Age of Personalized Medicine. «What is Personalized Medicine?» [Электронный документ]. — Режим доступа: http://ageofpersonalizedmedicine.org/objects/pdfs/Age_PM_factsheet.pdf.
7. Hamburg M. Paving the Way for Personalized Medicine: FDA’s Role in a New Era of Medical Product Development. U.S. Departament of Health and Human Services. 2013.
8. THE CASE FOR PERSONALIZED MEDIZINE. 4– th edition. Washington, 2014. р. 4.
9. Hadjiphilippou S. Cardiorenal syndrome: review of our current understanding / S. Hadjiphilippou, S. P. Kon // J. R. Soc. Med. 2016. Vol. 109, N 1. P. 12–17.
10. Наточин Ю.В. Особенности физиологии почки у детей / Ю. В. Наточин // Детская нефрология: руководство для врачей / Под ред. М. С. Игнатовой. 3-е изд., перераб. и доп. Москва: МИА, 2011. Гл. 3. С. 42–64.
11. Alexander BT. Fetal Programming and Cardiovascular Pathology / B. T. Alexander, J.H. Dasinger, S. Intapad // Compr. Physiol. 2015. Vol. 2, N 5. P. 997–1025.
12. Koleganova N. Renal, cardiovascular and metabolic effects of fetal programming / N. Koleganova, K. Benz, G. Piecha, et al. // Nephrol. Dial. Transplant. 2012. Vol. 27, N 8. P. 3003–3007.
13. Dötsch J. Fetal programming and renal function / J. Dötsch, C. Plank, K. Amam // Pediatr Nephrol. 2012. Vol. 27, N 4. P. 513–520.
14. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart / J. S. Carvalho, L. D. Allan, R. Chaoui, et al. // Ultrasound Obstet. Gynecol. 2013. Vol. 41, N 3. P. 348–359.
15. Carvalho J. S. Fetal heart scanning in the first trimester / J.S. Carvalho // Prenat Diagn. 2004. Vol. 24. P. 1060–1067.
16. Leibovitch L. Short-term outcome among term singleton infants with intrapartum.
17. Oligohydramnios / L. Leibovitch, J. Kuint, E. Rosenfeld, et al. // Acta Paediatr. 2012. Vol. 101, N 7. P. 727–730.
18. Gardiner H. The case for fetal cardiac intervention / H. Gardiner // Heart. 2009. Vol. 95. P. 1648–1652.
Review
For citations:
Pervunina T.M., Vasichkina E.S., Erman M.V. Personalized approach in the management of children with cardiorenal syndrome (combined congenital heart and kidney defects). Russian Journal for Personalized Medicine. 2023;3(2):77-81. (In Russ.) https://doi.org/10.18705/2782-3806-2023-3-2-77-81
Views:
372
Email this article 